{"id":"systemic-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia and mood disturbances"},{"rate":null,"effect":"Immunosuppression and increased infection risk"},{"rate":null,"effect":"Osteoporosis (with chronic use)"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Cushingoid features (with prolonged use)"}]},"_chembl":{"chemblId":"CHEMBL1697787","moleculeType":"Small molecule","molecularWeight":"528.57"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone enters cells and binds to intracellular glucocorticoid receptors, which then translocate to the nucleus and modulate gene transcription. This leads to decreased production of pro-inflammatory cytokines, reduced immune cell activation and proliferation, and suppression of inflammatory responses. It is approximately 25–30 times more potent than endogenous cortisol.","oneSentence":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:10:38.148Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus, vasculitis)"},{"name":"Cerebral edema and increased intracranial pressure"},{"name":"Adrenocortical insufficiency"},{"name":"Severe allergic reactions"},{"name":"Certain malignancies (as adjunctive therapy)"},{"name":"Chronic obstructive pulmonary disease exacerbations"}]},"trialDetails":[{"nctId":"NCT07227597","phase":"PHASE1, PHASE2","title":"A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-29","conditions":"Small Cell Lung Cancer Extensive Stage","enrollment":170},{"nctId":"NCT07469488","phase":"PHASE4","title":"A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2026-04-30","conditions":"NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors","enrollment":122},{"nctId":"NCT06627309","phase":"","title":"Rapid dFLC Response Predict CHR in AL Amyloidosis","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-10-26","conditions":"Systemic AL Amyloidosis","enrollment":50},{"nctId":"NCT06192979","phase":"NA","title":"Optimize First-line Treatment for AL Amyloidosis With t (11; 14)","status":"RECRUITING","sponsor":"Jin Lu, MD","startDate":"2024-01-05","conditions":"Amyloidosis; Systemic, AL Amyloidosis","enrollment":41},{"nctId":"NCT07455396","phase":"PHASE2","title":"Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical Asthma","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2026-05-15","conditions":"Asthma (Diagnosis)","enrollment":159},{"nctId":"NCT05286814","phase":"PHASE2","title":"PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-10-24","conditions":"Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Intrahepatic Bile Duct Cancer","enrollment":70},{"nctId":"NCT07425678","phase":"PHASE4","title":"Comparison of Systemic Opioid (Morphine) and Pre-Incision Bilateral Scalp Nerve Block for Pain Management in Craniotomy Patients","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2025-01-01","conditions":"Supratentorial Tumors","enrollment":62},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":"Intravenous Lidocaine, Laparoscopic Surgery, Post Operative Recovery","enrollment":182},{"nctId":"NCT07101445","phase":"PHASE4","title":"Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-09-24","conditions":"Multiple Myeloma","enrollment":94},{"nctId":"NCT07388602","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)","status":"RECRUITING","sponsor":"Sinocelltech Ltd.","startDate":"2026-01-08","conditions":"Amyloidosis","enrollment":90},{"nctId":"NCT07201519","phase":"PHASE2","title":"Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy","status":"RECRUITING","sponsor":"Michael J Cavnar, MD","startDate":"2026-01-23","conditions":"Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma","enrollment":80},{"nctId":"NCT04822337","phase":"PHASE1, PHASE2","title":"Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2021-05-19","conditions":"Multiple Myeloma","enrollment":70},{"nctId":"NCT07353593","phase":"PHASE1","title":"Effect of Kinesio Tape Versus Systemic Dexamethasone on Postsurgical Sequels Following Extraction of Impacted Mandibular Third Molars","status":"COMPLETED","sponsor":"Ashraf elanzy","startDate":"2023-10-01","conditions":"Impacted Mandibular Third Molar Extraction","enrollment":30},{"nctId":"NCT02969837","phase":"PHASE2","title":"Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2017-07-10","conditions":"Multiple Myeloma","enrollment":46},{"nctId":"NCT05250973","phase":"PHASE2","title":"A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-03-01","conditions":"Amyloidosis","enrollment":151},{"nctId":"NCT07344246","phase":"NA","title":"Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-01","conditions":"Herpes Zoster Pain","enrollment":954},{"nctId":"NCT07341867","phase":"PHASE1","title":"Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype","status":"NOT_YET_RECRUITING","sponsor":"Andrew Hantel, MD","startDate":"2026-06","conditions":"Multiple Myeloma, Triple Negative Breast Cancer, Duffy Blood Group, Chemokine Receptor Gene Mutation","enrollment":90},{"nctId":"NCT07335887","phase":"PHASE2","title":"Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2026-01-01","conditions":"AL Amyloidosis (AL), t(11;14) Positive","enrollment":39},{"nctId":"NCT03366155","phase":"PHASE2","title":"Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-06-24","conditions":"Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma","enrollment":24},{"nctId":"NCT06842316","phase":"","title":"Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-04-10","conditions":"Inflammatory Disorder of Immune System, Spondylitis, Ankylosing, Arthritis, Rheumatoid","enrollment":100},{"nctId":"NCT03201965","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-10-05","conditions":"Amyloidosis","enrollment":416},{"nctId":"NCT04891289","phase":"PHASE2","title":"Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-05-07","conditions":"Intrahepatic Cholangiocarcinoma","enrollment":164},{"nctId":"NCT01312857","phase":"PHASE2","title":"Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2011-03-07","conditions":"Metastatic Colorectal Cancer","enrollment":75},{"nctId":"NCT03500445","phase":"PHASE2","title":"Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2019-02-13","conditions":"Myeloma, Multiple Myeloma","enrollment":75},{"nctId":"NCT01659658","phase":"PHASE3","title":"Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis","status":"TERMINATED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2012-12-26","conditions":"Relapsed or Refractory Systemic Light Chain Amyloidosis","enrollment":177},{"nctId":"NCT00492999","phase":"PHASE2","title":"Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2007-05","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":64},{"nctId":"NCT05451771","phase":"PHASE1, PHASE2","title":"Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis","status":"RECRUITING","sponsor":"Rajshekhar Chakraborty, MD","startDate":"2022-10-26","conditions":"AL Amyloidosis","enrollment":53},{"nctId":"NCT07035314","phase":"NA","title":"The Effect of Systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Vs Intraoperative Infiltration of Steroids in Tonsillar Bed Following Tonsillectomy on Post Tonsillectomy Pain.","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-03-08","conditions":"Tonsillitis Chronic, Tonsillitis Recurrent, OSA - Obstructive Sleep Apnea","enrollment":75},{"nctId":"NCT05819541","phase":"PHASE2","title":"Treating Exacerbations of Asthma With Oral Montelukast in Children","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-10-20","conditions":"Status Asthmaticus","enrollment":90},{"nctId":"NCT04921189","phase":"PHASE2","title":"Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2021-12-31","conditions":"Out-Of-Hospital Cardiac Arrest, Postcardiac Arrest Syndrome","enrollment":160},{"nctId":"NCT01816971","phase":"PHASE2","title":"Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2013-01","conditions":"Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma","enrollment":76},{"nctId":"NCT05727163","phase":"PHASE2","title":"FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2022-07-29","conditions":"Colorectal Cancer Metastatic","enrollment":194},{"nctId":"NCT06428630","phase":"EARLY_PHASE1","title":"Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus","status":"WITHDRAWN","sponsor":"Tufts University","startDate":"2025-05-01","conditions":"Oral Lichen Planus, Oral Lichenoid Reaction","enrollment":""},{"nctId":"NCT06946069","phase":"NA","title":"Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-01","conditions":"Vitiligo, NB-UVB","enrollment":40},{"nctId":"NCT05706636","phase":"NA","title":"T Central Memory Cells in Early Localized Non-Segmental Vitiligo","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-02-01","conditions":"Vitiligo","enrollment":22},{"nctId":"NCT04251715","phase":"PHASE2","title":"mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2021-04-28","conditions":"Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8","enrollment":5},{"nctId":"NCT06624436","phase":"PHASE4","title":"Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2024-10-24","conditions":"Sepsis, Neuroinflammatory Response, Immunosuppresion","enrollment":52},{"nctId":"NCT05707156","phase":"","title":"Prospective Observational Study on the Incidence of Opportunistic Fungal Infections","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-07-05","conditions":"Pneumocystis Jirovecii Infection, Pneumocystis, Cryptococcosis","enrollment":12032},{"nctId":"NCT06603662","phase":"PHASE4","title":"Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department","status":"RECRUITING","sponsor":"WellSpan Health","startDate":"2025-02-24","conditions":"Osteoarthritis, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder","enrollment":192},{"nctId":"NCT00059930","phase":"PHASE1","title":"Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-01","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":38},{"nctId":"NCT00200200","phase":"PHASE2","title":"Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-11-19","conditions":"Hepatic Metastases, Colon Cancer, Rectal Cancer","enrollment":73},{"nctId":"NCT01862315","phase":"PHASE2","title":"Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-05","conditions":"Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma, Cholangiolar Carcinoma","enrollment":55},{"nctId":"NCT05486481","phase":"PHASE1, PHASE2","title":"Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)","status":"WITHDRAWN","sponsor":"Alfred Chung, MD","startDate":"2024-01-08","conditions":"AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease","enrollment":""},{"nctId":"NCT06306612","phase":"NA","title":"CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-03-21","conditions":"Prostate Cancer","enrollment":192},{"nctId":"NCT06242028","phase":"","title":"Use of Dexamethasone Via Two Different Methods in PENG Block","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2023-08-30","conditions":"Pain, Acute, Postoperative Pain, Hip Fractures","enrollment":44},{"nctId":"NCT05895838","phase":"PHASE3","title":"The Danish Out-of-Hospital Cardiac Arrest Study","status":"RECRUITING","sponsor":"Christian Hassager","startDate":"2023-06-16","conditions":"Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome","enrollment":1000},{"nctId":"NCT06342466","phase":"PHASE2","title":"Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis","status":"RECRUITING","sponsor":"Jin Lu, MD","startDate":"2024-05-06","conditions":"Systemic Amyloidosis","enrollment":40},{"nctId":"NCT06713733","phase":"NA","title":"Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery","status":"RECRUITING","sponsor":"B.P. Koirala Institute of Health Sciences","startDate":"2024-09-25","conditions":"Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin Chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery","enrollment":50},{"nctId":"NCT06686641","phase":"","title":"Incidence of Macular Edema in a Uveitis Population","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2024-05-01","conditions":"Macular Edema, Non-infectious Uveitis","enrollment":1550},{"nctId":"NCT06418477","phase":"PHASE2","title":"Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-06-15","conditions":"Monoclonal Gammopathy of Renal Significance","enrollment":20},{"nctId":"NCT06537518","phase":"NA","title":"The Difference Between Using Local and General Dexamethasone in Arthroscopic Anterior Cruciate Ligament Repair","status":"COMPLETED","sponsor":"Benha University","startDate":"2022-05-01","conditions":"ACL Injury","enrollment":123},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT02348216","phase":"PHASE1, PHASE2","title":"Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Kite, A Gilead Company","startDate":"2015-04-21","conditions":"Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma (TFL)","enrollment":307},{"nctId":"NCT06318013","phase":"","title":"Perineural and Systemic Dexamethasone Use in Dental Surgeries in Terms of Anesthesia Duration and Postop Complaints","status":"COMPLETED","sponsor":"Karamanoğlu Mehmetbey University","startDate":"2024-03-27","conditions":"Impacted Third Molar Tooth","enrollment":60},{"nctId":"NCT06376214","phase":"NA","title":"Daratumumab for Patients With Light Chain Amyloidosis","status":"RECRUITING","sponsor":"Nanjing University School of Medicine","startDate":"2023-01-01","conditions":"Light Chain (AL) Amyloidosis","enrollment":100},{"nctId":"NCT06297681","phase":"","title":"Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2024-03-15","conditions":"M-protein Related Cardiac Disease","enrollment":40},{"nctId":"NCT02102789","phase":"PHASE3","title":"A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis","status":"RECRUITING","sponsor":"Yuhong Li","startDate":"2014-03","conditions":"Metastatic Colorectal Cancer","enrollment":142},{"nctId":"NCT03500874","phase":"PHASE3","title":"Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM","status":"TERMINATED","sponsor":"Sun Yat-sen University","startDate":"2018-05-28","conditions":"Colorectal Cancer, Liver Metastases, HAI","enrollment":92},{"nctId":"NCT06179030","phase":"","title":"Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2022-05-01","conditions":"Diabetic Macular Edema, Inflammation","enrollment":80},{"nctId":"NCT00520767","phase":"PHASE2","title":"Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease","status":"COMPLETED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2007-09","conditions":"Primary Systemic Amyloidosis, Light Chain Deposition Disease","enrollment":35},{"nctId":"NCT04276090","phase":"NA","title":"Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma","status":"TERMINATED","sponsor":"Michael J Cavnar, MD","startDate":"2020-05-01","conditions":"Bile Duct Neoplasms, Colorectal Neoplasms","enrollment":21},{"nctId":"NCT04479748","phase":"PHASE4","title":"DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses","status":"COMPLETED","sponsor":"Prism Vision Group","startDate":"2020-10-01","conditions":"Cataract","enrollment":13},{"nctId":"NCT03678428","phase":"PHASE3","title":"FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM","status":"TERMINATED","sponsor":"Sun Yat-sen University","startDate":"2021-12-31","conditions":"Metastatic Colorectal Cancer, Liver Metastases","enrollment":92},{"nctId":"NCT03493061","phase":"PHASE2","title":"A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2018-02-01","conditions":"Colo-rectal Cancer, Liver Metastases","enrollment":60},{"nctId":"NCT04852874","phase":"NA","title":"Quadratus Lumborum Block as an Anesthetic Method for Percutaneous Nephrolithotomy","status":"UNKNOWN","sponsor":"Al-Azhar University","startDate":"2021-04-03","conditions":"Quadratus Lumborum Block, Percutaneous Nephrolithotomy, Local Anesthesia","enrollment":100},{"nctId":"NCT03372707","phase":"NA","title":"Cuff Leak Test and Airway Obstruction in Mechanically Ventilated ICU","status":"COMPLETED","sponsor":"McMaster University","startDate":"2018-07-05","conditions":"Laryngeal Edema","enrollment":100},{"nctId":"NCT04027322","phase":"PHASE2, PHASE3","title":"Inhaled Steroids for Acute Pharyngitis.","status":"COMPLETED","sponsor":"Oman Medical Speciality Board","startDate":"2019-06-01","conditions":"Acute Pharyngitis","enrollment":200},{"nctId":"NCT05115357","phase":"NA","title":"Pecto-Intercostal Fascial Block Versus Transversus Thoracic Muscle Plane Block in Cardiac Surgery","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2021-12-24","conditions":"Pecto-Intercostal Fascial Block, Transversus Thoracis Muscle Plane Block, Cardiac Surgery","enrollment":90},{"nctId":"NCT01078454","phase":"PHASE3","title":"Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-11","conditions":"Light Chain Deposition Disease, Primary Systemic Amyloidosis","enrollment":11},{"nctId":"NCT04619693","phase":"","title":"Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2020-11-18","conditions":"Pneumonia, Viral, SARS-Cov-2","enrollment":79},{"nctId":"NCT02275702","phase":"PHASE4","title":"Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients","status":"COMPLETED","sponsor":"Laval University","startDate":"2014-10","conditions":"Lung Cancer","enrollment":100},{"nctId":"NCT02516423","phase":"PHASE3","title":"Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone","status":"UNKNOWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2015-12","conditions":"Solitary Osseous Plasmacytoma","enrollment":11},{"nctId":"NCT04817982","phase":"PHASE2","title":"Does Perineural Dexamethasone Increase the Duration of an Ulnar Nerve Block When Controlling for Systemic Effects?","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2021-04-07","conditions":"Anesthesia, Local","enrollment":16},{"nctId":"NCT00695201","phase":"PHASE1","title":"Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-08","conditions":"Colon Cancer, Rectal Cancer","enrollment":52},{"nctId":"NCT03876041","phase":"PHASE4","title":"Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-09-01","conditions":"Systemic Inflammatory Response Syndrome","enrollment":60},{"nctId":"NCT00981708","phase":"PHASE1, PHASE2","title":"Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)","status":"COMPLETED","sponsor":"University of Athens","startDate":"2008-02","conditions":"Amyloidosis","enrollment":37},{"nctId":"NCT04849117","phase":"","title":"Effect of Bilateral Transversus Thoracis Muscle Plane Block in Patients Undergoing Coronary Artery Bypass Graft Surgery.","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2018-01-01","conditions":"Coronary Artery Disease, Pain Syndrome","enrollment":100},{"nctId":"NCT04765826","phase":"NA","title":"Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2021-01-25","conditions":"Vitiligo","enrollment":60},{"nctId":"NCT04530864","phase":"PHASE4","title":"Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy","status":"UNKNOWN","sponsor":"Prism Vision Group","startDate":"2021-01","conditions":"Dry Eye Disease, Cataract Surgery, Ocular Surface Disease","enrollment":35},{"nctId":"NCT03308084","phase":"PHASE3","title":"Use of Local Intraoperative Steroid in MIS TLIF","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2015-11-13","conditions":"Dysphasia","enrollment":105},{"nctId":"NCT03311425","phase":"PHASE3","title":"Effect of Local Intraoperative Steroid on Dysphagia After ACDF","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2014-08-01","conditions":"Dysphagia","enrollment":140},{"nctId":"NCT02266433","phase":"PHASE3","title":"Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2012-08","conditions":"DeQuervains Tenosynovitis, Lateral Epicondylitis, Tennis Elbow","enrollment":245},{"nctId":"NCT01938729","phase":"PHASE1","title":"Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-09-05","conditions":"Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma, Cholangiolar Carcinoma","enrollment":8},{"nctId":"NCT02836158","phase":"PHASE2, PHASE3","title":"Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL","status":"RECRUITING","sponsor":"Navy General Hospital, Beijing","startDate":"2010-09","conditions":"Primary Central Nervous System Lymphoma","enrollment":100},{"nctId":"NCT02657785","phase":"PHASE2, PHASE3","title":"Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy","status":"RECRUITING","sponsor":"Navy General Hospital, Beijing","startDate":"2010-09","conditions":"Primary Central Nervous System Lymphoma","enrollment":100},{"nctId":"NCT03000660","phase":"PHASE1","title":"Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2017-01","conditions":"AL Amyloidosis","enrollment":3},{"nctId":"NCT00598169","phase":"PHASE1","title":"Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2007-11","conditions":"Lymphoma","enrollment":23},{"nctId":"NCT02322242","phase":"PHASE4","title":"The Effects of Dexamethasone on Low Dose Interscalene Brachial Plexus Block","status":"COMPLETED","sponsor":"Dr. Stephen Choi","startDate":"2015-01","conditions":"Shoulder Surgery, Nerve Block","enrollment":182},{"nctId":"NCT04445506","phase":"","title":"Short Term Corticosteroids in SARS-CoV2 Patients","status":"COMPLETED","sponsor":"The Miriam Hospital","startDate":"2020-04-01","conditions":"Corticosteroids, Covid19, SARS-CoV 2","enrollment":50},{"nctId":"NCT03044353","phase":"PHASE2","title":"Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-07-10","conditions":"Amyloidosis","enrollment":7},{"nctId":"NCT02046070","phase":"PHASE2","title":"Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2014-03-05","conditions":"Multiple Myeloma","enrollment":148},{"nctId":"NCT03069950","phase":"PHASE2","title":"Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver","status":"WITHDRAWN","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-02-28","conditions":"Colorectal Adenocarcinoma Metastatic to the Liver","enrollment":""},{"nctId":"NCT02872597","phase":"PHASE1","title":"Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-09-05","conditions":"Status Asthmaticus","enrollment":30},{"nctId":"NCT03901768","phase":"PHASE4","title":"Effects of Combined Topical and Systemic Steroid Administrations on Better Early Postoperative Pain Management in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2018-04-26","conditions":"Total Knee Replacement","enrollment":180},{"nctId":"NCT01383928","phase":"PHASE1, PHASE2","title":"Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2011-10-31","conditions":"Multiple Myeloma","enrollment":64},{"nctId":"NCT02224170","phase":"NA","title":"Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy","status":"TERMINATED","sponsor":"Yonsei University","startDate":"2014-11","conditions":"Gallbladder Polyp, Asymptomatic Gallstones Without Cholecystitis","enrollment":8},{"nctId":"NCT02462148","phase":"PHASE4","title":"Perineural Steroids for Peripheral Nerve Blocks","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-07","conditions":"Osteoarthritis, Knee","enrollment":85},{"nctId":"NCT02464176","phase":"PHASE4","title":"Systemic Steroids for Peripheral Nerve Blocks","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-06","conditions":"Osteoarthritis, Hip","enrollment":115},{"nctId":"NCT00064337","phase":"PHASE2","title":"S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2004-01","conditions":"Multiple Myeloma, Plasma Cell Myeloma","enrollment":104},{"nctId":"NCT01428492","phase":"PHASE1","title":"Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma","status":"COMPLETED","sponsor":"Novartis","startDate":"2011-12","conditions":"Multiple Myeloma","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":180,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dexamethasone Sodium Phosphate Injection"],"phase":"marketed","status":"active","brandName":"Systemic dexamethasone","genericName":"Systemic dexamethasone","companyName":"Zealand University Hospital","companyId":"zealand-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus, vasculitis), Cerebral edema and increased intracranial pressure, Adrenocortical insufficiency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}